vesicles
Colonel
An interesting new study. They found that the current SARS-CoV-2 virus can attack white blood cells, especially the T-cells. This is surprising because T-cells have almost no ACE2 receptors. So this means the current SARS-CoV-2 can infect cells with no or low levels of ACE2 receptor. Previous coronaviruses, like SARS-CoV or MERS, cannot infect cells with no/low level of the ACE2 receptor. It has been thought that SARS-CoV-2 should also specifically target cells with high levels of ACE2 receptors. However, this new study suggests otherwise. This may explain why the new virus can infect people so efficiently. And also explain why people with defective immune responses become so critically ill upon infection.
The fortunate part is that, once entering the T-cells, the SARS-CoV-2 virus canNOT replicate anymore. They stay dormant and die with the host T-cells. This is good...
The new study also tested one of their peptide drugs that has been designed to inhibit viral fusion with host cells. They found some success, which is encouraging...
The fortunate part is that, once entering the T-cells, the SARS-CoV-2 virus canNOT replicate anymore. They stay dormant and die with the host T-cells. This is good...
The new study also tested one of their peptide drugs that has been designed to inhibit viral fusion with host cells. They found some success, which is encouraging...